NT ‐ proBNP and Sarcopenia: Marker, Mediator, or Misclassification?

Key Points

• The aim is to explore the role of NT proBNP in relation to sarcopenia, considering its impact as a potential marker or mediator.
• Evaluation of NT proBNP levels in relation to sarcopenia
• Critical analysis of existing literature on the topic
• Theoretical exploration rather than empirical data collection
• NT proBNP may serve as a helpful biomarker for sarcopenia.
• The interpretation of its role is debated, raising potential misclassification issues.

Abstract